CN114867449A - Oil-in-water type emulsified cosmetic - Google Patents
Oil-in-water type emulsified cosmetic Download PDFInfo
- Publication number
- CN114867449A CN114867449A CN202080087123.7A CN202080087123A CN114867449A CN 114867449 A CN114867449 A CN 114867449A CN 202080087123 A CN202080087123 A CN 202080087123A CN 114867449 A CN114867449 A CN 114867449A
- Authority
- CN
- China
- Prior art keywords
- oil
- mass
- cosmetic
- less
- alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 119
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 55
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 48
- 239000000194 fatty acid Substances 0.000 claims abstract description 48
- 229930195729 fatty acid Natural products 0.000 claims abstract description 48
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 39
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 38
- 239000002736 nonionic surfactant Substances 0.000 claims abstract description 24
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 23
- 239000006097 ultraviolet radiation absorber Substances 0.000 claims abstract description 12
- 239000002612 dispersion medium Substances 0.000 claims abstract description 10
- 229920002545 silicone oil Polymers 0.000 claims description 39
- 125000002015 acyclic group Chemical group 0.000 claims description 24
- 239000003795 chemical substances by application Substances 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 17
- 230000002087 whitening effect Effects 0.000 claims description 17
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 12
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 12
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 claims description 12
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 claims description 10
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 9
- 239000002562 thickening agent Substances 0.000 claims description 9
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 claims description 8
- 229960000735 docosanol Drugs 0.000 claims description 6
- 235000021357 Behenic acid Nutrition 0.000 claims description 5
- 229940116226 behenic acid Drugs 0.000 claims description 5
- 229960000541 cetyl alcohol Drugs 0.000 claims description 5
- 235000021355 Stearic acid Nutrition 0.000 claims description 4
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 4
- 239000008117 stearic acid Substances 0.000 claims description 4
- 239000000839 emulsion Substances 0.000 abstract description 80
- 239000007764 o/w emulsion Substances 0.000 abstract description 12
- 239000003921 oil Substances 0.000 description 93
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 42
- 229920001223 polyethylene glycol Polymers 0.000 description 37
- -1 isodecyl malate Chemical compound 0.000 description 30
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 22
- 238000000034 method Methods 0.000 description 20
- 239000012071 phase Substances 0.000 description 19
- 239000002245 particle Substances 0.000 description 17
- 239000004973 liquid crystal related substance Substances 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- 150000005215 alkyl ethers Chemical class 0.000 description 13
- 238000004945 emulsification Methods 0.000 description 13
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 12
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 12
- 239000004205 dimethyl polysiloxane Substances 0.000 description 11
- 125000005456 glyceride group Chemical group 0.000 description 10
- 238000002156 mixing Methods 0.000 description 10
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 9
- 125000004122 cyclic group Chemical group 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 150000001298 alcohols Chemical class 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 229920001451 polypropylene glycol Polymers 0.000 description 8
- 239000008346 aqueous phase Substances 0.000 description 7
- 239000007844 bleaching agent Substances 0.000 description 7
- WOKDXPHSIQRTJF-UHFFFAOYSA-N 3-[3-[3-[3-[3-[3-[3-[3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]-2-hydroxypropoxy]propane-1,2-diol Chemical compound OCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)COCC(O)CO WOKDXPHSIQRTJF-UHFFFAOYSA-N 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 239000004359 castor oil Substances 0.000 description 5
- 235000019438 castor oil Nutrition 0.000 description 5
- 108010025899 gelatin film Proteins 0.000 description 5
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- 239000006096 absorbing agent Substances 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- JPPRXACMNPYJNK-UHFFFAOYSA-N 1-docosoxydocosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCCCCCC JPPRXACMNPYJNK-UHFFFAOYSA-N 0.000 description 3
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 3
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 150000002894 organic compounds Chemical class 0.000 description 3
- 239000002453 shampoo Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- UYZQWKKNVBJVOF-UHFFFAOYSA-N 1-decoxytetradecane Chemical compound CCCCCCCCCCCCCCOCCCCCCCCCC UYZQWKKNVBJVOF-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 2
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 2
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 2
- MRIXVKKOHPQOFK-UHFFFAOYSA-N 4-methoxysalicylic acid Chemical compound COC1=CC=C(C(O)=O)C(O)=C1 MRIXVKKOHPQOFK-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 229940074052 glyceryl isostearate Drugs 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- VVOAZFWZEDHOOU-UHFFFAOYSA-N magnolol Chemical compound OC1=CC=C(CC=C)C=C1C1=CC(CC=C)=CC=C1O VVOAZFWZEDHOOU-UHFFFAOYSA-N 0.000 description 2
- 239000000693 micelle Substances 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001515 polyalkylene glycol Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229960001860 salicylate Drugs 0.000 description 2
- 235000003441 saturated fatty acids Nutrition 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 2
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- URJOWNUVTORLNY-UHFFFAOYSA-N (5-hexadecanoyloxy-4-oxopyran-2-yl) hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC1=CC(=O)C(OC(=O)CCCCCCCCCCCCCCC)=CO1 URJOWNUVTORLNY-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- AVZIYOYFVVSTGQ-RBWRNIRVSA-N (z)-octadec-9-enoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O AVZIYOYFVVSTGQ-RBWRNIRVSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 1
- HFWHTGSLDKKCMD-UHFFFAOYSA-N 2,2-bis(octanoyloxymethyl)butyl octanoate Chemical compound CCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCC)COC(=O)CCCCCCC HFWHTGSLDKKCMD-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- OUCGJMIVSYHBEC-UHFFFAOYSA-N 2-ethylhexyl 2-ethylhexanoate Chemical compound CCCCC(CC)COC(=O)C(CC)CCCC OUCGJMIVSYHBEC-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- ZSNLEVJATWJBLU-UHFFFAOYSA-N 2-tert-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(C(C)(C)C)(OC)C(=O)C1=CC=CC=C1 ZSNLEVJATWJBLU-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- ZGSCRDSBTNQPMS-UJURSFKZSA-N 3-O-Ethylascorbic acid Chemical compound CCOC1=C(O)C(=O)O[C@@H]1[C@@H](O)CO ZGSCRDSBTNQPMS-UJURSFKZSA-N 0.000 description 1
- LPDGWMLCUHULJF-UHFFFAOYSA-N 3-piperidin-1-ylpropanoic acid Chemical compound OC(=O)CCN1CCCCC1 LPDGWMLCUHULJF-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 description 1
- IZZIWIAOVZOBLF-UHFFFAOYSA-N 5-methyloxysalicylic acid Natural products COC1=CC=C(O)C(C(O)=O)=C1 IZZIWIAOVZOBLF-UHFFFAOYSA-N 0.000 description 1
- MVJSIAIXMFGVSA-UHFFFAOYSA-N 6-(2-hexyldecoxy)-6-oxohexanoic acid Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCC(O)=O MVJSIAIXMFGVSA-UHFFFAOYSA-N 0.000 description 1
- BCNMHJYHRSTPJY-UHFFFAOYSA-N 8-methylnonyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCC(C)C BCNMHJYHRSTPJY-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- KIENGQUGHPTFGC-JLAZNSOCSA-N L-ascorbic acid 6-phosphate Chemical compound OP(=O)(O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O KIENGQUGHPTFGC-JLAZNSOCSA-N 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 235000021353 Lignoceric acid Nutrition 0.000 description 1
- CQXMAMUUWHYSIY-UHFFFAOYSA-N Lignoceric acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 CQXMAMUUWHYSIY-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- YDMGZMPBQOPVLZ-NSHDSACASA-N OC([C@H](CC1=CNC=N1)NC(CCCCCCC(S)S)=O)=O Chemical compound OC([C@H](CC1=CNC=N1)NC(CCCCCCC(S)S)=O)=O YDMGZMPBQOPVLZ-NSHDSACASA-N 0.000 description 1
- DNZGTMUOLYMUKJ-UHFFFAOYSA-N OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CCCCCCCCCCCCCC(O)=O Chemical compound OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CCCCCCCCCCCCCC(O)=O DNZGTMUOLYMUKJ-UHFFFAOYSA-N 0.000 description 1
- MMQZBEXYFLXHEN-UHFFFAOYSA-N OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O Chemical compound OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O MMQZBEXYFLXHEN-UHFFFAOYSA-N 0.000 description 1
- WTAYIFXKJBMZLY-XZABIIKCSA-N OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O Chemical compound OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O WTAYIFXKJBMZLY-XZABIIKCSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 239000008118 PEG 6000 Substances 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N Trimethylene glycol Natural products OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- RDVFKSXIXOQIDZ-UHFFFAOYSA-N [3-hydroxy-2,2-bis(hydroxymethyl)propyl] 2,2,3,3-tetraethylhexanoate Chemical compound CCCC(CC)(CC)C(CC)(CC)C(=O)OCC(CO)(CO)CO RDVFKSXIXOQIDZ-UHFFFAOYSA-N 0.000 description 1
- OOHTWBUKWQKKEE-UHFFFAOYSA-N [6-(diethylamino)-6-hydroxy-7-oxo-7-phenylheptyl] benzoate Chemical compound C=1C=CC=CC=1C(=O)C(O)(N(CC)CC)CCCCCOC(=O)C1=CC=CC=C1 OOHTWBUKWQKKEE-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- BJRNKVDFDLYUGJ-ZIQFBCGOSA-N alpha-Arbutin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-ZIQFBCGOSA-N 0.000 description 1
- 229940033280 alpha-arbutin Drugs 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 229940067599 ascorbyl glucoside Drugs 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- WMNULTDOANGXRT-UHFFFAOYSA-N bis(2-ethylhexyl) butanedioate Chemical compound CCCCC(CC)COC(=O)CCC(=O)OCC(CC)CCCC WMNULTDOANGXRT-UHFFFAOYSA-N 0.000 description 1
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 229940105984 diethylhexyl succinate Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- KWABLUYIOFEZOY-UHFFFAOYSA-N dioctyl butanedioate Chemical compound CCCCCCCCOC(=O)CCC(=O)OCCCCCCCC KWABLUYIOFEZOY-UHFFFAOYSA-N 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- AGDANEVFLMAYGL-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCCCCCC(O)=O AGDANEVFLMAYGL-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- SELHWUUCTWVZOV-UHFFFAOYSA-N dodecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CCCCCCCCCCCC(O)=O SELHWUUCTWVZOV-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- FARYTWBWLZAXNK-WAYWQWQTSA-N ethyl (z)-3-(methylamino)but-2-enoate Chemical compound CCOC(=O)\C=C(\C)NC FARYTWBWLZAXNK-WAYWQWQTSA-N 0.000 description 1
- 229940068171 ethyl hexyl salicylate Drugs 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- BOJSDHZZKKYWAS-UHFFFAOYSA-N tetrakis(trimethylsilyl)silane Chemical compound C[Si](C)(C)[Si]([Si](C)(C)C)([Si](C)(C)C)[Si](C)(C)C BOJSDHZZKKYWAS-UHFFFAOYSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- BUBJWNWWARPCBH-UHFFFAOYSA-N tris(trimethylsilyl)methylsilicon Chemical compound C[Si](C)(C)C([Si])([Si](C)(C)C)[Si](C)(C)C BUBJWNWWARPCBH-UHFFFAOYSA-N 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
- A61K8/894—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/14—Preparations for removing make-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Provided is an oil-in-water emulsion cosmetic which has excellent emulsion stability and can exhibit a sense of disintegration as a sense of use. The oil-in-water type emulsion cosmetic of the present disclosure contains: a dispersion medium comprising water; and oil droplets dispersed in the dispersion medium, the oil droplets containing an oil component, a linear higher fatty acid having 16 or more carbon atoms, a monohydric higher alcohol, and a nonionic surfactant, the oil component containing at least one selected from a polar oil having an IOB of 0.10 or more and an ultraviolet absorber having an IOB of 0.10 or more, and the viscosity (V) measured at 0.6rpm when the B-type viscometer is used in an atmosphere at 30 ℃ (V) 0.6rpm ) With the viscosity (V) measured at 12rpm 12rpm ) Viscosity ratio (V) 0.6rpm /V 12rpm ) Is 7.9 or more.
Description
Technical Field
The present disclosure relates to an oil-in-water type emulsion cosmetic.
Background
In recent years, oil-in-water emulsion cosmetics have been developed which have emulsion stability and exhibit various feelings of use.
Patent document 1 discloses an emulsion composition which is obtained by blending (a) 0.01 to 5% by weight of a polysiloxane-polyoxyalkylene copolymer, (b) 0.05 to 1% by weight of a nonionic surfactant, (c) 10 to 30% by weight of a humectant, and (d) 1 to 50% by weight of urea, exhibits an excellent moisturizing effect while reducing irritation of urea, and has a very refreshing feeling in use.
Patent document 2 discloses an emulsion composition containing a poorly soluble drug, an oily component containing two or more higher alcohols, water, and a surfactant, wherein one of the higher alcohols is behenyl alcohol, which emulsion composition is excellent in usability and has excellent dispersion stability and emulsion stability of the drug.
Patent document 3 discloses an emulsion composition which is obtained by blending 0.01 to 5.0 mass% of a polysiloxane-polyoxyalkylene copolymer (a) and 0.05 to 1.0 mass% of a nonionic surfactant (B) or 0.05 to 5.0 mass% of a higher fatty acid having 12 or more carbon atoms with 0.05 to 50.0 mass% of a glycoside in which urea and/or ascorbic acid is blended, and which is excellent in stability and has a fresh feeling of use without stickiness.
Documents of the prior art
Patent document
Patent document 1: japanese patent laid-open No. 2001-247427
Patent document 2: japanese unexamined patent publication No. 2001-354548
Patent document 3: japanese laid-open patent publication No. 2002-249665
Disclosure of Invention
Problems to be solved by the invention
An emulsified composition constituting a cosmetic contains an oil component. In oil, polar oil has oil properties and on the other hand has polarity, and therefore has properties of being easily compatible with water as compared with nonpolar oil. Therefore, the emulsion balance between the aqueous phase and the oil phase is liable to be lost, and it is difficult to improve the emulsion stability of the oil-in-water type emulsion cosmetic containing the polar oil. Moreover, it is more difficult to adjust the feeling of use of an oil-in-water type emulsion cosmetic containing such a polar oil.
Therefore, the subject of the present disclosure is to provide an oil-in-water type emulsion cosmetic which is excellent in emulsion stability and can exhibit a sense of disintegration as a sense of use.
Means for solving the problems
Scheme 1
An oil-in-water type emulsified cosmetic composition comprising:
a dispersion medium comprising water; and
oil droplets dispersed in the dispersion medium described above,
the oil droplets contain an oil component, a linear higher fatty acid having 16 or more carbon atoms, a monohydric higher alcohol, and a nonionic surfactant,
the oil component contains at least one kind selected from polar oil with IOB of 0.10 or more and ultraviolet absorbent with IOB of 0.10 or more,
viscosity (V) measured at 0.6rpm using a B-type viscometer at 30 ℃ in an atmosphere 0.6rpm ) With the viscosity (V) measured at 12rpm 12rpm ) Viscosity ratio (V) 0.6rpm /V 12rpm ) Is 7.9 or more.
Scheme 2
The cosmetic preparation according to claim 1, wherein the mass ratio of the linear higher fatty acid to the monohydric higher alcohol is 0.50 or more.
Scheme 3
The cosmetic preparation according to claim 1 or 2, wherein the linear higher fatty acid, the higher alcohol, and the nonionic surfactant form an interfacial film of the oil droplets in an atmosphere at 25 ℃.
Scheme 4
The cosmetic preparation according to any one of claims 1 to 3, wherein the linear higher fatty acid is at least one selected from stearic acid and behenic acid, and the higher alcohol is at least one selected from cetyl alcohol, isostearyl alcohol, stearyl alcohol and behenyl alcohol.
Scheme 5
The cosmetic according to any one of aspects 1 to 4, wherein the oil component contains at least one selected from the group consisting of a polar oil having an IOB of 0.10 or more and an ultraviolet absorber having an IOB of 0.10 or more in an amount of 50% by mass or more.
Scheme 6
The cosmetic material according to any one of aspects 1 to 5, further comprising a dihydric higher alcohol.
(plan 7)
The cosmetic according to any one of aspects 1 to 6, wherein the oil component further comprises a volatile acyclic silicone oil.
Scheme 8
The cosmetic according to any one of claims 1 to 7, further comprising at least one selected from a whitening agent and an anti-inflammatory agent.
Scheme 9
The cosmetic preparation according to any one of aspects 1 to 8, wherein the content of the thickener is 1% by mass or less.
ADVANTAGEOUS EFFECTS OF INVENTION
According to the present disclosure, an oil-in-water emulsion cosmetic that is excellent in emulsion stability and can exhibit a sense of disintegration as a sense of use can be provided.
Detailed Description
Hereinafter, embodiments of the present disclosure will be described in detail. The present disclosure is not limited to the following embodiments, and various modifications may be made within the scope of the present invention.
The oil-in-water type emulsion cosmetic (sometimes simply referred to as "cosmetic") of the present disclosure contains: a dispersion medium comprising water; and oil droplets dispersed in the dispersion medium, the oil droplets containing an oil component, a linear higher fatty acid having 16 or more carbon atoms, a monohydric higher alcohol, and a nonionic surfactant, wherein the oil component in the oil droplets contains at least one selected from a polar oil having an IOB of 0.10 or more and an ultraviolet absorber, and in addition, the viscosity (V) measured at 0.6rpm when the type B viscometer is used in an atmosphere of 30 ℃, (V) is measured 0.6rpm ) With the viscosity (V) measured at 12rpm 12rpm ) Viscosity ratio (V) 0.6rpm /V 12rpm ) Is 7.9 or more.
Although not limited by the principle, the principle of action that such an oil-in-water type emulsion cosmetic is excellent in emulsion stability and can achieve a specific viscosity ratio in the sense of disintegration is considered as follows.
When a polar oil having an IOB of 0.10 or more or an ultraviolet absorber having an IOB of 0.10 or more, which can correspond to such a polar oil, is contained as an oil component, the emulsion balance is generally disturbed, and therefore, the emulsion stability of the cosmetic is expected to be lowered. Therefore, even though various documents disclose an oil-in-water type emulsion composition containing a nonpolar oil, a linear higher fatty acid having 16 or more carbon atoms, a monohydric higher alcohol, and a nonionic surfactant, those skilled in the art would not normally think of changing the nonpolar oil in such a composition to a polar oil.
The present inventors have found that even when a polar oil is used as the oil component, the emulsion particles (oil droplets) prepared using a specific material, that is, a linear higher fatty acid having 16 or more carbon atoms, a monohydric higher alcohol, and a nonionic surfactant have excellent emulsion stability.
The main reason for the expression of such emulsion stability is considered to be: for example, a linear higher fatty acid having 16 or more carbon atoms, a monohydric higher alcohol, and a nonionic surfactant form an interface film such as a gel film or a liquid crystal film based on lamellar liquid crystals or the like that are stronger than micelle structures or the like at normal temperature, for example, in an atmosphere of 25 ℃ or 30 ℃, around emulsified particles, and a polar oil that easily breaks the emulsion equilibrium is included.
Further, the presence of such an interfacial film is also considered to affect the feeling of disintegration in the cosmetic of the present disclosure. That is, unlike the emulsified particles having an interface film, for example, particles having a micelle structure, the interface film is broken at once when a load exceeding a limit value is applied, and thus a sense of disintegration is considered to be exhibited.
The terms in this disclosure are defined as follows.
In the present disclosure, the "disintegrating feeling" refers to a feeling of use in which the viscosity of a cosmetic is reduced at a glance when a load is applied to the cosmetic. Specifically, the "disintegrating feeling" in the present disclosure means a feeling of use in which the viscosity is high and the fluidity is low at the stage of placing the cosmetic on the skin or the like, but if the cosmetic is applied to the skin or the like by rubbing against each other, the viscosity is reduced and the state of dry and high fluidity is obtained. The disintegration feeling was measured by using a B-type viscometer (TVB-10, manufactured by Toyobo industries Co., Ltd., rotor No. L3) at 30 ℃ in an atmosphere of 0.6rpm (V) 0.6rpm ) With the viscosity (V) measured at 12rpm 12rpm ) Viscosity ratio (V) 0.6rpm /V 12rpm ) The term "viscosity ratio" means a state of 7.9 or more.
Oil-in-water type emulsified cosmetic preparation
The oil-in-water emulsion cosmetic of the present disclosure has excellent emulsion stability. The emulsion stability here means, for example, a state in which the particles are not separated at 0 to 37 ℃ for 4 weeks, preferably at 50 ℃ for 4 weeks, and preferably a state in which the emulsified particles (oil droplets) have little or no change in size.
In addition, the oil-in-water type emulsion cosmetic of the present disclosure may exhibit a sense of disintegration. Such a sense of disintegration can be determined by the viscosity ratio (V) as described above 0.6rpm /V 12rpm ) To specify. The viscosity ratio may be 7.9 or more, 8.0 or more, 8.1 or more, 8.3 or more, 8.5 or more, 8.7 or more, 9.0 or more, 9.5 or more, or 10.0 or more. The upper limit of the viscosity ratio is not particularly limited, and may be, for example, 30.0 or less, 25.0 or less, 20.0 or less, or 15.0 or less.
The viscosity ratio of the oil-in-water type emulsion cosmetic can be controlled by adjusting at least one of the following conditions (a) to (c):
(a) the mass ratio of the linear higher fatty acid to the monohydric higher alcohol.
(b) Oil components (e.g., polar oils and volatile acyclic silicone oils), linear higher fatty acids having 16 or more carbon atoms, monohydric higher alcohols, and nonionic surfactants, and combinations thereof.
(c) The proportion of the polar oil and/or the volatile acyclic silicone oil in the oil component.
Viscosity (V) measured at 12rpm as an oil-in-water type emulsion cosmetic of the present disclosure 12rpm ) The amount of the surfactant is not particularly limited, and may be appropriately determined in consideration of the application performance, the feeling of use, and the like of the cosmetic. For example, the viscosity (V) was measured using a B-type viscometer (TVB-10, manufactured by Toyobo industries Co., Ltd., rotor number L3) at 30 ℃ in an atmosphere 12rpm ) The viscosity of the aqueous dispersion may be 20,000 mPas or less, 18,000 mPas or less, 15,000 mPas or less, 12,000 mPas or less, 10,000 mPas or less, 8,000 mPas or less, 6,000 mPas or less, or 5,000 mPas or less, or may be 2,000 mPas or more, 2,200 mPas or more, 2,500 mPas or more, 2,700 mPas or more, or 3,000 mPas or more.
Dispersion medium
The oil-in-water type emulsified cosmetic of the present disclosure contains water as a dispersion medium.
(Water)
The amount of water to be blended is not particularly limited, and may be, for example, 50 mass% or more, 60 mass% or more, 70 mass% or more, or 80 mass% or more, or 95 mass% or less, 90 mass% or less, or 85 mass% or less with respect to the total amount of the cosmetic material, from the viewpoint of emulsion stability, disintegrating feeling, or the like.
The water that can be used in the oil-in-water emulsion cosmetic of the present disclosure is not particularly limited, and water that can be used in cosmetics, quasi drugs, and the like can be used. For example, ion-exchanged water, distilled water, ultrapure water, tap water, or the like can be used.
Oil drop
Oil droplets as an oil phase or a dispersed phase in the oil-in-water type emulsion cosmetic contain an oil component, a linear higher fatty acid having 16 or more carbon atoms, a monohydric higher alcohol, and a nonionic surfactant. Among these components, a linear higher fatty acid having 16 or more carbon atoms, a monohydric higher alcohol, and a nonionic surfactant can form an interfacial film of oil droplets. Such an interface film can be confirmed using, for example, an optical microscope.
The present inventors have found that oil droplets (emulsified particles) having such an interfacial film can be obtained, for example, by preparing an oil-in-water emulsion composition by a liquid crystal emulsion method in which a linear higher fatty acid having 16 or more carbon atoms, a monohydric higher alcohol, and a nonionic surfactant are mixed together with a highly polar oil component while heating to prepare a solution, and the solution is added to heated water.
The average particle size of the oil droplets as the dispersed phase is not particularly limited. The average particle size of the oil droplets may be, for example, 10 μm or less, 7 μm or less, 5 μm or less, or 3 μm or less immediately after the production. The lower limit of the average particle diameter is not particularly limited, and may be, for example, 500nm or more, 700nm or more, or 1 μm or more. Here, the average particle diameter of the oil droplets may be defined as an average value of the projected area equivalent circle diameters of 10 or more, preferably 100 or more oil droplets observed with an optical microscope.
(oil component)
The content of the oil component in the oil-in-water type emulsion cosmetic of the present disclosure is not particularly limited, and may be, for example, 0.5 mass% or more, 1 mass% or more, 3 mass% or more, 5 mass% or more, 7 mass% or more, 10 mass% or more, 13 mass% or more, or 15 mass% or more, or 50 mass% or less, 40 mass% or less, 30 mass% or less, 25 mass% or less, or 20 mass% or less, relative to the total amount of the cosmetic.
The oil component contains at least one selected from a polar oil having an IOB of 0.10 or more and an ultraviolet absorber having an IOB of 0.10 or more. The cosmetic composition of the present disclosure can improve the emulsion stability of oil droplets by a linear higher fatty acid having 16 or more carbon atoms, a monohydric higher alcohol, and a nonionic surfactant, and therefore can highly contain a polar oil having an IOB of 0.10 or more and an ultraviolet absorber. The oil component may be contained in an amount of 50 mass% or more, 60 mass% or more, 65 mass% or more, 70 mass% or more, or 75 mass% or more based on the whole oil component. The upper limit of the oil content is not particularly limited, and may be, for example, 100 mass% or less, 95 mass% or less, 90 mass% or less, 85 mass% or less, 80 mass% or less, or 75 mass% or less. Here, an organic ultraviolet absorber having an IOB of 0.10 or more can be regarded as an oil component.
The IOB value of the polar oil and the ultraviolet absorber may be, for example, 0.10 or more, 0.11 or more, 0.12 or more, or 0.13 or more, and may be 0.50 or less, 0.45 or less, or 0.40 or less. Here, the IOB value is a abbreviation of Inorganic/Organic Balance, and is a value indicating a ratio of an Inorganic value to an Organic value, and is an index showing a degree of polarity of an Organic compound. Specifically, the IOB value is expressed as an inorganic value/organic value. The "inorganic value" and the "organic value" are each set, for example, such that the "inorganic value" and the "organic value" corresponding to each atom or functional group are set as the "organic value" and the "hydroxyl group" corresponding to each atom or functional group in the molecule are 20 and 100, and the "inorganic value" and the "organic value" of all the atoms and functional groups in the organic compound are added up to calculate the IOB value of the organic compound (see, for example, athetimics, "regulatory concept figure-base 3099 と," (organic concept map-base and application-) ", p.11 to 17, published in three co-publications, published in 1984).
Polar oil having an IOB of 0.10 or more
Examples of polar oils satisfying such conditions include isopropyl myristate (IOB value ═ 0.18), octyl palmitate (IOB value ═ 0.13), isopropyl palmitate (IOB value ═ 0.16), butyl stearate (IOB value ═ 0.14), hexyl laurate (IOB value ═ 0.17), myristyl myristate (IOB value ═ 0.11), decyl oleate (IOB value ═ 0.11), isononyl isononanoate (IOB value ═ 0.20), isotridecyl isononanoate (IOB value ═ 0.15), cetyl ethylhexanoate (IOB value ═ 0.13), pentaerythritol tetraethylhexanoate (IOB value ═ 0.35), diethylhexyl succinate (IOB value ═ 0.32), dioctyl succinate (IOB value ═ 0.36), ethylene glycol distearate (IOB value ═ 0.0.25), diglycerol distearate (IOB value) (IOB value ═ 0.28), isodecyl malate (IOB value ═ 0.25), isodecyl stearate (IOB value) Trimethylolpropane triisostearate (IOB value ═ 0.16), glycerol tri-2-ethylhexanoate (triisooctanoate) (IOB value ═ 0.35), trimethylolpropane trioctanoate (IOB value ═ 0.33), trimethylolpropane triisostearate (IOB value ═ 0.16), diisobutyl adipate (IOB value ═ 0.46), N-lauroyl-L-glutamic acid-2-octyldodecyl ester (IOB value ═ 0.29), 2-hexyldecyl adipate (IOB value ═ 0.16), diisopropyl sebacate (IOB value ═ 0.40), 2-ethylhexyl palmitate (IOB value ═ 0.13), 2-ethylhexyl ethylhexanoate (IOB value ═ 0.2), glyceryl triisostearate (IOB value ═ 0.16), dipivalonic acid PPG-3(IOB value ═ 0.52), glyceryl tri (caprylic/capric) ester (IOB value ═ 0.33), and the like. These may be used alone or in combination of two or more.
An ultraviolet absorber having an IOB of 0.10 or more
Examples of the ultraviolet absorbers satisfying such conditions include organic ultraviolet absorbers such as ethylhexyl methoxycinnamate, octocrylene, polysiloxane-15, t-butyl methoxydibenzoylmethane, ethylhexyl triazone, bis-ethylhexyl oxyphenol methoxyphenyl triazine, diethylamino hydroxybenzoyl hexyl benzoate, benzophenone-3, methylene bis-benzotriazolyl tetramethylbutyl phenol, homosalate, and ethylhexyl salicylate. These ultraviolet absorbers may be used singly or in combination of two or more.
(C16 or more straight chain higher fatty acid)
The content of the linear higher fatty acid having 16 or more carbon atoms in the oil-in-water type emulsion cosmetic of the present disclosure is not particularly limited, and may be, for example, 0.10% by mass or more, 0.15% by mass or more, 0.20% by mass or more, 0.25% by mass or more, or 0.30% by mass or more, or 5.0% by mass or less, 3.0% by mass or less, or 1.0% by mass or less, relative to the total amount of the cosmetic.
The oil-in-water type emulsion cosmetic of the present disclosure may contain a higher fatty acid other than the linear higher fatty acid having 16 or more carbon atoms, for example, a linear or branched higher fatty acid having less than 16 carbon atoms or a branched higher fatty acid having 16 or more carbon atoms, within a range that does not affect the effects of the present invention, but from the viewpoint of disintegration feeling and emulsion stability, these other higher fatty acids are preferably contained in a range of, for example, less than 0.10 mass%, 0.05 mass% or less, or 0.01 mass% or less with respect to the total amount of the cosmetic, and further, these other higher fatty acids are more preferably not contained in the cosmetic.
The number of carbon atoms of the linear higher fatty acid may be 16 or more, or 18 or more, or 25 or less, 24 or less, or 22 or less.
Examples of such a linear higher fatty acid include saturated fatty acids such as palmitic acid, stearic acid, arachidic acid, behenic acid (n-docosanoic acid) and lignoceric acid, and unsaturated fatty acids such as palmitoleic acid, oleic acid, linoleic acid, α -linolenic acid, γ -linolenic acid, arachidonic acid, eicosapentaenoic acid and docosahexaenoic acid. Among them, from the viewpoint of the feeling of disintegration, saturated fatty acids are preferable, stearic acid and behenic acid are more preferable, and behenic acid is particularly preferable. These straight chain higher fatty acids may be used alone or in combination of two or more.
(monohydric higher alcohol)
The content of the monohydric higher alcohol in the oil-in-water type emulsion cosmetic of the present disclosure is not particularly limited, and may be, for example, 0.1 mass% or more, 0.3 mass% or more, 0.5 mass% or more, 0.7 mass% or more, or 1.0 mass% or more, or 5.0 mass% or less, 4.0 mass% or less, or 3.0 mass% or less, based on the total amount of the cosmetic.
The monohydric higher alcohol is not particularly limited, and for example, a saturated or unsaturated monohydric aliphatic alcohol may be used, and may be either linear or branched, but is preferably linear. From the viewpoint of emulsion stability and sense of disintegration, preferred is a monohydric higher alcohol which is solid at room temperature, for example, and which, together with a linear higher fatty acid and a nonionic surfactant, is likely to form an interface film such as a gel film or a liquid crystal film made of a lamellar liquid crystal or the like at room temperature or higher. Here, the term "normal temperature" in the present disclosure means a range of 5 ℃ to 35 ℃.
Examples of such monohydric higher alcohols include higher alcohols having a melting point of 40 ℃ or higher, for example, monohydric aliphatic alcohols having 10 to 30 carbon atoms. Specific examples thereof include stearyl alcohol, isostearyl alcohol, oleyl alcohol, octyldodecanol, cholesterol, sitosterol, cetyl alcohol (cetyl alcohol), cetostearyl alcohol, decyltetradecyl alcohol, phytosterol, hexyldecanol, behenyl alcohol, lauryl alcohol, lanolin alcohol, and hydrogenated lanolin alcohol. Among them, cetyl alcohol, isostearyl alcohol, stearyl alcohol, and behenyl alcohol are preferable, and behenyl alcohol is more preferable, from the viewpoint of emulsion stability and disintegration feeling. These higher alcohols may be used singly or in combination of two or more.
a. Mass ratio of higher alcohol to straight chain higher fatty acid
The mass ratio of the linear higher fatty acid having 16 or more carbon atoms to the monohydric higher alcohol is preferably 0.50 or more, 0.55 or more, 0.60 or more, or 0.65 or more, and preferably 2.0 or less, 1.7 or less, 1.5 or less, or 1.3 or less, from the viewpoints of emulsion stability, disintegrating feeling, and the like. In some embodiments, when the oil-in-water type emulsion cosmetic of the present disclosure contains a volatile acyclic silicone oil described later as an oil component, such a mass ratio may be 0.30 or more, 0.35 or more, 0.40 or more, 0.45 or more, 0.50 or more, 0.55 or more, 0.60 or more, or 0.65 or more, and may be 2.0 or less, 1.7 or less, 1.5 or less, or 1.3 or less.
(nonionic surfactant)
The content of the nonionic surfactant in the oil-in-water type emulsion cosmetic of the present disclosure is not particularly limited, and may be, for example, 0.1 mass% or more, 0.3 mass% or more, or 0.5 mass% or more, or 5.0 mass% or less, 4.0 mass% or less, 3.0 mass% or less, or 2.0 mass% or less with respect to the total amount of the cosmetic.
The nonionic surfactant is not particularly limited, and examples thereof include polyoxyalkylene alkyl ethers, polyalkylene glycol fatty acid esters, POE alkyl ethers, POE/POP alkyl ethers, PEG fatty acid esters, polyglycerol fatty acid esters, POE glycerol fatty acid esters, isostearic acid PEG glycerol esters, and silicone surfactants. These may be used alone or in combination of two or more.
Examples of the polyoxyalkylene alkyl ether include polyoxyethylene behenyl ether and polyoxyethylene stearyl ether.
Examples of the polyalkylene glycol fatty acid ester include polyethylene glycol monostearate and polyethylene glycol monooleate.
Examples of the POE alkyl ethers include, for example, POE (2) lauryl ether, POE (4.2) lauryl ether, POE (9) lauryl ether, POE (5.5) cetyl ether, POE (7) cetyl ether, POE (10) cetyl ether, POE (15) cetyl ether, POE (20) cetyl ether, POE (23) cetyl ether, POE (4) stearyl ether, POE (20) stearyl ether, POE (7) oleyl ether, POE (10) oleyl ether, POE (15) oleyl ether, POE (20) oleyl ether, POE (50) oleyl ether, POE (10) behenyl ether, POE (20) behenyl ether, POE (30) behenyl ether, POE (2) (C12-15) alkyl ether, POE (4) (C12-15) alkyl ether, POE (10) (C12-15) alkyl ether, POE (5) secondary alkyl ether, POE (7) secondary alkyl ether, POE (9) alkyl ether, POE (12) alkyl ether, and the like.
Examples of the POE/POP alkyl ether include POE (1) polyoxypropylene (POP) (4) cetyl ether, POE (10) POP (4) cetyl ether, POE (20) POP (8) cetyl ether, POE (20) POP (6) decyltetradecyl ether, and POE (30) POP (6) decyltetradecyl ether.
Examples of the PEG fatty acid ester include polyethylene glycol monolaurate (hereinafter, abbreviated as PEG) (10), PEG (10) monostearate, PEG (25) monostearate, PEG (40) monostearate, PEG (45) monostearate, PEG (55) monostearate, PEG (100) monostearate, PEG (10) monooleate, PEG distearate, PEG diisostearate, PEG (40) hydrogenated castor oil, PEG (50) hydrogenated castor oil, PEG (60) hydrogenated castor oil, PEG (100) hydrogenated castor oil, and the like.
Examples of the polyglycerin fatty acid esters include hexaglycerol monolaurate, hexaglycerol monomyristate, hexaglycerol monostearate, hexaglycerol monooleate, decaglycerol monolaurate, decaglycerol monomyristate, decaglycerol monostearate, decaglycerol monoisostearate, decaglycerol monooleate, decaglycerol distearate, and decaglycerol diisostearate.
Examples of POE glycerin fatty acid esters include Polyoxyethylene (POE) (5) glycerin monostearate, POE (15) glycerin monostearate, POE (5) glycerin monooleate, and POE (15) glycerin monooleate.
Examples of the isostearic acid PEG glyceride include isostearic acid PEG (8) glyceride, isostearic acid PEG (10) glyceride, isostearic acid PEG (15) glyceride, isostearic acid PEG (20) glyceride, isostearic acid PEG (25) glyceride, isostearic acid PEG glyceride (30), isostearic acid PEG (40) glyceride, isostearic acid PEG (50) glyceride, isostearic acid PEG (60) glyceride, and the like.
Examples of the silicone surfactants include PEG (7) polydimethylsiloxane and PEG (10) polydimethylsiloxane.
Among them, from the viewpoint of emulsion stability, disintegrating feeling and the like, PEG fatty acid esters, PEG glyceryl isostearate and silicone surfactants are preferable, PEG (60) hydrogenated castor oil, PEG (60) glyceryl isostearate and PEG (10) polydimethylsiloxane are more preferable, and they may be used alone, but they are preferably used in combination.
Optional ingredients
The oil-in-water type emulsion cosmetic of the present disclosure may contain various components as appropriate within a range not affecting the effect of the present invention. Examples of the various components include additional components that can be generally blended in a cosmetic. Examples thereof include a humectant such as 1, 3-butanediol, propylene glycol and glycerin for explosives, an anionic surfactant, a cationic surfactant, an amphoteric surfactant, a water-soluble polymer, an oil-soluble polymer, a film-forming agent such as a polysaccharide organosilicate, a sequestering agent, a lower alcohol such as ethanol, a polyhydric alcohol such as PEG6000 and dipropylene glycol, a higher alcohol other than the above, various extracts, a sugar, an amino acid, an organic amine, a polymer emulsion, a chelating agent, an ultraviolet absorber other than the above, an ultraviolet scattering agent such as zinc oxide, a pH adjuster, a skin nutrient, a vitamin, a drug, a quasi-drug, a cosmetic, and other water-soluble drugs, a whitening agent, an anti-inflammatory agent, an antioxidant, a buffer, an antiseptic, an antioxidant aid, a thickener, a dispersing agent, a propellant, an organic powder, a surfactant, an organic silicon dioxide gas, a silicone oil, and the like, Clay minerals, pigments, dyes, pigments, perfumes, acid components, alkali components, nonpolar oils such as polydimethylsiloxane, etc. These optional ingredients may be used alone or in combination of two or more, and may be appropriately compounded in the oil phase and/or the aqueous phase.
Among such additives, higher alcohols other than the above are preferably used from the viewpoint of suppression of crystallization of the interface film, sense of disintegration, and the like. The higher alcohol is preferably a dihydric higher alcohol, and batyl alcohol is particularly preferable.
In addition, since it is generally difficult to improve the emulsion stability of an oil-in-water type emulsion cosmetic using a polar oil, a thickener, particularly a water-soluble thickener, is generally used to ensure the emulsion stability of such a cosmetic. However, compounding of a thickener may improve emulsion stability, but may adversely affect the feeling of disintegration, that is, achievement of a specific viscosity ratio, and, in addition, may easily give a sticky feeling.
On the other hand, since the emulsion particles (oil droplets) in the oil-in-water emulsion cosmetic of the present disclosure are prepared using specific materials, that is, a linear higher fatty acid having 16 or more carbon atoms, a monohydric higher alcohol, and a nonionic surfactant, the emulsion stability is excellent, and therefore the cosmetic of the present disclosure may not substantially contain a thickener. That is, the thickener may be blended in a proportion of 1 mass% or less, 0.5 mass% or less, 0.1 mass% or less, 0.01 mass% or less, or 0.001 mass% or less with respect to the total amount of the cosmetic, but it is advantageous not to use the thickener from the viewpoint of a sense of disintegration and the like.
In some embodiments, the oil-in-water type emulsion cosmetic of the present disclosure may be blended with a nonpolar oil component such as polydimethylsiloxane as the oil component. Among them, when a volatile acyclic silicone oil is blended, the film strength of an interfacial film such as a gel film or a liquid crystal film formed around oil droplets can be further improved, and therefore, a whitening agent, an anti-inflammatory agent, or other agents that tend to deteriorate emulsion stability can be blended. Further, the use of the volatile acyclic silicone oil capable of improving the film strength of the interfacial film can also increase the static viscosity while suppressing an increase in the dynamic viscosity of the cosmetic, and therefore an increase in the viscosity ratio, that is, a feeling of disintegration can be more easily expressed. The term "volatility" as used herein means that the volatile matter is more than 5% when left at 105 ℃ for 3 hours under atmospheric pressure. From the viewpoint of obtaining excellent film strength and disintegrating feeling, the volatile component that is an indicator of volatility is preferably 10% or more, 20% or more, 40% or more, 50% or more, 60% or more, 80% or more, or 100%. Alternatively, as an indicator of volatility, the boiling point at 1 atmosphere (101.325kPa) can be used. From the viewpoint of obtaining excellent film strength and sense of disintegration, the boiling point is preferably 250 ℃ or lower, 240 ℃ or lower, or 230 ℃ or lower, and is preferably 80 ℃ or higher, 100 ℃ or higher, 120 ℃ or higher, 150 ℃ or higher, or 160 ℃ or higher. In the present disclosure, "nonvolatile" means that the volatile content is 5% or less when left at 105 ℃ for 3 hours.
As the volatile acyclic silicone oil, for example, a volatile linear silicone oil or a volatile branched silicone oil can be used. Among them, volatile linear silicone oils are preferable. The volatile acyclic silicone oil may be used alone or in combination of two or more.
Examples of the volatile linear silicone oil include low-molecular-weight linear dimethylpolysiloxanes such as dimethylpolysiloxane having a viscosity of 0.65cSt (which may be referred to as "polydimethylsiloxane"), dimethylpolysiloxane having a viscosity of 1cSt, dimethylpolysiloxane having a viscosity of 1.5cSt, and dimethylpolysiloxane having a viscosity of 2 cSt. Here, these viscosities refer to kinematic viscosities under an atmosphere of 25 ℃.
Examples of the volatile branched silicone oil include low molecular weight branched silicones such as methylpolytrimethylsiloxane, tris (trimethylsilyl) methylsilane, and tetrakis (trimethylsilyl) silane.
The content of the volatile acyclic silicone oil in the oil-in-water emulsion cosmetic of the present disclosure is not particularly limited, and may be, for example, 0.1% by mass or more, 0.3% by mass or more, 0.5% by mass or more, 0.7% by mass or more, or 1.0% by mass or more, and may be less than 20.0% by mass, 15.0% by mass or less, 10.0% by mass or less, 9.0% by mass or less, 8.0% by mass or less, 7.0% by mass or less, 6.0% by mass or less, 5.0% by mass or less, 4.0% by mass or less, or 3.0% by mass or less, relative to the total amount of the cosmetic. Alternatively, the content of the volatile acyclic silicone oil may be 15 mass% or more, 17 mass% or more, or 20 mass% or more, or may be about 50 mass% or less, about 40 mass% or less, or about 30 mass% or less, relative to the total amount of the oil component.
In several embodiments, the oil-in-water type emulsion cosmetic of the present disclosure may be compounded with a volatile cyclic silicone oil and a non-volatile non-cyclic silicone oil as an oil component. However, when the volatile acyclic silicone oil is blended to further improve the film strength of the interface film, the content of the volatile cyclic silicone oil and the nonvolatile acyclic silicone oil is preferably less than 20.0 mass%, 15.0 mass% or less, 10.0 mass% or less, 7.0 mass% or less, 5.0 mass% or less, 3.0 mass% or less, or 1.0 mass% or less, respectively, with respect to the total amount of the cosmetic. Alternatively, the content of the volatile cyclic silicone oil and the nonvolatile acyclic silicone oil is preferably 10.0% by mass or less, 7.0% by mass or less, 5.0% by mass or less, 3.0% by mass or less, or 1.0% by mass or less, respectively, with respect to the total amount of the oil component. Further, the volatile cyclic silicone oil and/or the nonvolatile acyclic silicone oil is more preferably not blended in the oil component, and particularly preferably not blended in the oil component.
In several embodiments, the oil-in-water type emulsion cosmetic of the present disclosure may be compounded with at least one selected from a whitening agent and an anti-inflammatory agent. Whitening agents and anti-inflammatory agents, particularly acid-type whitening agents and anti-inflammatory agents, salt-type whitening agents and anti-inflammatory agents, generally tend to deteriorate the emulsion stability. However, the oil-in-water type emulsion cosmetic of the present disclosure, which is further improved in the film strength of the interface film by blending a volatile acyclic silicone oil, can exhibit good emulsion stability even when such a whitening agent and an anti-inflammatory agent are blended.
The whitening agent is not particularly limited as long as it exhibits a whitening effect. Examples thereof include at least one acid type whitening agent selected from ascorbic acid (L-ascorbic acid), tranexamic acid, glycyrrhizic acid, nicotinic acid, kojic acid, ellagic acid, 1-piperidinepropionic acid, 3-O-ethyl-L-ascorbic acid, and alkoxysalicylic acid (e.g., 4-methoxysalicylic acid); and at least one salt type whitening agent selected from ascorbate, thrombonate, glycyrrhetate, nicotinate, kojic acid salt, ellagic acid salt, 1-piperidine propionate, 3-O-ethyl-L-ascorbate, and alkoxy salicylate (such as 4-methoxy salicylate). Examples of the salt-type whitening agent include alkali metal salts such as sodium salt and potassium salt; alkaline earth metal salts such as calcium salts and magnesium salts; a zinc salt; a ferric salt; an ammonium salt; salts with basic amino acids such as arginine, lysine, histidine and ornithine; and salts with amines such as monoethanolamine, diethanolamine, and triethanolamine. Examples of the whitening agent include ascorbic acid derivatives (e.g., ascorbyl glucoside), tranexamic acid derivatives, glycyrrhizic acid derivatives, nicotinic acid derivatives, kojic acid derivatives (e.g., kojic dipalmitate), ellagic acid derivatives, alkoxysalicylic acid derivatives, hydroquinone, α -arbutin, β -arbutin, niacinamide, astaxanthin, dimercaptooctanoylhistidine (Na/zinc), chamomile extract, licorice extract, placenta extract, rosemary extract, 4-n-butylresorcinol, and magnolol. The whitening agents may be used alone or in combination of two or more.
The anti-inflammatory agent is not particularly limited as long as it exhibits an anti-inflammatory action. However, agents exhibiting both whitening and anti-inflammatory effects are treated as whitening agents in the present disclosure. Examples of the anti-inflammatory agent include magnesium L-ascorbyl phosphate, glycyrrhizin, dipotassium glycyrrhizinate, ammonium glycyrrhizinate, and allantoin.
The blending amount of the whitening agent and the anti-inflammatory agent is not particularly limited, and may be, for example, 0.01 mass% or more, 0.05 mass% or more, 0.1 mass% or more, 0.3 mass% or more, 0.5 mass% or more, 0.7 mass% or more, or 1.0 mass% or more, and may be 15.0 mass% or less, 10.0 mass% or less, 8.0 mass% or less, or 5.0 mass% or less, independently of each other, with respect to the total amount of the cosmetic.
Use of oil-in-water type emulsified cosmetic
The oil-in-water type emulsion cosmetic of the present disclosure can exhibit a sense of disintegration such that the viscosity of the cosmetic is reduced at a glance when a load is applied. Therefore, the cosmetic of the present disclosure exhibiting such a feeling of use can be used as a cosmetic applied by spreading on the skin or the like, for example. Here, the cosmetic applied to the skin may contain a substance called a skin preparation for external use.
The formulation of the cosmetic of the present disclosure is not particularly limited, and examples thereof include a liquid, an emulsion, a cream, a gel, a spray, and a mousse. Here, the "spray" in the present disclosure may include a mist type spray, an aerosol type spray, and the like.
The form of the cosmetic preparation of the present disclosure is not particularly limited, and examples thereof include facial cosmetics such as lotions, beauty liquids, lotions, and masks; makeup cosmetics such as foundation make-up; sunscreen cosmetic materials (sunscreens); a body cosmetic; skin washing materials such as makeup remover, body shampoo, etc.; hair cosmetics such as shampoo, hair tonic, hair conditioner, shampoo, rinse-off hair conditioner, and hair tonic; ointments and the like.
Method for producing oil-in-water type emulsified cosmetic preparation
The oil-in-water type emulsion cosmetic of the present disclosure can be prepared by a known method such as a dispersion method or an aggregation method.
The dispersion method is a method of making a bulk of a dispersed phase into fine particles by a mechanical force. Specifically, the emulsification is performed by the crushing force of an emulsifier, and examples of such a method include a high-pressure emulsification method in which a high shearing force is applied by using a high-pressure homogenizer.
The agglutination method is a colloid modulation method using surface chemical properties, and is a method in which a material that is a dispersed phase is made supersaturated by some means from a state in which a sample に is uniformly (Japanese text) dissolved, and appears. As specific methods, a liquid crystal emulsification method, an HLB temperature emulsification method, a phase inversion emulsification method, a nonaqueous emulsification method, a D phase emulsification method, and the like are known.
Among these methods, the oil-in-water emulsion cosmetic of the present disclosure is advantageously prepared by a liquid crystal emulsion method from the viewpoint of emulsion stability, disintegrating feeling, and the like. An interface film such as a gel film or a liquid crystal film made of a lamellar liquid crystal or the like is easily formed in the vicinity of the interface of emulsified particles prepared by a liquid crystal emulsification method. As a result, aggregation and coalescence of the emulsified particles are suppressed, emulsion stability is improved, and a sense of disintegration is more likely to be expressed by a strong interface film.
As a method for preparing the cosmetic of the present disclosure by the liquid crystal emulsion method, for example, the following method can be employed. The polar oil, the linear higher fatty acid having 16 or more carbon atoms, the monohydric higher alcohol, the nonionic surfactant, the optional components, and the like can be used in the same manner.
A polar oil, a linear higher fatty acid having 16 or more carbon atoms, a monohydric higher alcohol, a nonionic surfactant, and optionally added oil-soluble optional components are mixed together while heating to about 70 to 90 ℃ to prepare an oil phase solution. Next, the oil-in-water type emulsion cosmetic of the present disclosure can be prepared by mixing water and optionally added water-soluble optional ingredients while heating to about 70 to 90 ℃ to prepare an aqueous phase solution, slowly adding the oil phase solution to the aqueous phase solution while stirring, and then cooling to room temperature.
In the conventional liquid crystal emulsification method, since it was confirmed that an interfacial film such as a gel film or a liquid crystal film is formed around emulsified particles by a lamellar liquid crystal or the like at a stage of being cooled to room temperature, it is considered that the emulsified particles of the present disclosure form such an interfacial film around the emulsified particles at the same stage.
Examples
The present invention will be described in further detail below with reference to examples, but the present invention is not limited thereto. In the following, unless otherwise specified, the blending amount is expressed as mass%.
Examples 1 to 7 and comparative examples 1 to 8
The following evaluations were made with respect to the oil-in-water emulsion cosmetic compositions obtained by the formulations shown in tables 1 to 3 and the production methods shown below, and the results are shown in tables 1 to 3.
Evaluation method
(evaluation of viscosity)
The viscosity of the cosmetic was evaluated by using a B-type viscometer (TVB-10, manufactured by Toyobo industries, Ltd.) under conditions of a spindle number L3, 30 ℃, 0.6rpm and 12 rpm. The results are shown in the table together with the viscosity ratios calculated from the results. Here, in the table,the viscosity measured at 0.6rpm is marked as "V 0.6rpm ", the viscosity measured at 12rpm is marked as" V 12rpm ", the viscosity ratio is marked as" V 0.6rpm /V 12rpm ”。
(evaluation of emulsion stability)
The size of oil droplets within 1 hour after the preparation of the emulsified cosmetic and the size of oil droplets after storage at 50 ℃ for 4 weeks were observed by an optical microscope, and the emulsion stability was evaluated based on the following criteria:
a: little change in droplet size occurs.
B: the oil droplet size is slightly increased.
C: the oil droplet size is significantly increased or the cosmetics are separated.
Method for producing cosmetic
(example 1)
An oil-in-water type emulsion cosmetic was produced by the liquid crystal emulsion method shown below using the formulations shown in table 1. Here, the numbers shown below correspond to the numbers of the display component names on the left side of the prescription in table 1.
While heating to 70 to 90 ℃, the oil components of Nos. 10 to 13 and the ultraviolet absorbers of Nos. 14 and 15 were uniformly mixed, and then the nonionic surfactants of Nos. 1 and 2, the higher alcohols of Nos. 3 and 4, and the behenic acid of No.5, which is a straight-chain higher fatty acid, were further mixed to prepare an oil phase solution.
Next, the materials No.16 to No.23 were added to the ion-exchanged water No.24 while heating to 70 to 90 ℃ and uniformly mixed to prepare an aqueous solution.
The oil-phase solution was slowly added to the aqueous phase solution while heating the solution to 70 to 90 ℃, and the mixture was uniformly dispersed in a dispenser and then cooled to room temperature, thereby obtaining the oil-in-water type emulsion cosmetic of example 1.
(example 2 and comparative examples 1 to 7)
Oil-in-water emulsion cosmetics of example 2 and comparative examples 1 to 7 were obtained in the same manner as in example 1 except that the components and blending amounts of the oil phase solution and the aqueous phase solution were changed to those shown in table 1.
(examples 3 to 6)
Oil-in-water emulsion cosmetic compositions of examples 3 to 6 were obtained in the same manner as in example 1 except that the components and blending amounts of the oil phase solution and the aqueous phase solution were changed to those shown in table 2.
(example 7 and comparative example 8)
Oil-in-water type emulsified cosmetic materials of example 7 and comparative example 8 were obtained in the same manner as in example 1 except that the components and blending amounts of the oil phase solution and the water phase solution were changed to those shown in table 3.
[ Table 1]
Results
As is clear from table 1, the emulsion cosmetics of comparative examples 1 to 7 had a viscosity ratio of less than 7.9, and therefore, even when these cosmetics were applied to the skin and spread, no sense of disintegration was felt. In particular, it is found that the emulsion cosmetics of comparative examples 6 to 7 are poor in emulsion stability. On the other hand, the emulsion cosmetics of examples 1 to 2 were excellent in emulsion stability and had a viscosity ratio of 7.9 or more, and therefore, when these cosmetics were applied to the skin and spread, it was confirmed that they exhibited a good sense of disintegration.
[ Table 2]
TABLE 2
Results
As is clear from comparison between example 1 and example 3, when a volatile acyclic silicone oil polydimethylsiloxane (1.5cst) was used in place of the volatile cyclic silicone oil cyclopentademethicone, the viscosity ratio of the emulsified cosmetic was increased. Further, if these cosmetics were applied to the skin and spread, it was confirmed that the cosmetic of example 3 exhibited a more favorable sense of disintegration. Such properties are considered to be affected by the difference in compatibility of the cyclic silicone oil and the acyclic silicone oil with the components constituting the interfacial film. That is, the acyclic silicone oil has a property of being less compatible with components constituting the interface film than cyclic silicone oils such as cyclopentadimethylsiloxane. Therefore, if a volatile acyclic silicone oil is used as the oil component, the interfacial film constituent component is more easily separated from the oil component than in the case of a cyclic silicone oil that is easily compatible. As a result, it is considered that more interfacial film-forming components move to the vicinity of the interface between the oil phase and the water phase, and thus a stronger interfacial film is formed, and the above-described performance can be exhibited.
The emulsion cosmetics of examples 4 to 6 were prepared by blending the cosmetics of example 3 with various whitening agents. Such whitening agents generally tend to deteriorate emulsion stability, but it has been confirmed that in the case of a cosmetic prepared by using a volatile acyclic silicone oil, the emulsion stability is excellent even when the whitening agent is blended. Further, since the emulsion cosmetics of examples 4 to 6 had a viscosity ratio of 7.9 or more although they contained a whitening agent, it was confirmed that these cosmetics exhibited a good sense of disintegration when applied to the skin and spread.
[ Table 3]
TABLE 3
Results
As is clear from comparison between comparative example 8 and example 7, when a volatile acyclic silicone oil is used in place of a nonvolatile acyclic silicone oil as the oil component, the whitening agent can exhibit good emulsion stability and can achieve a viscosity ratio of 7.9 or more.
Further, it was confirmed that by changing the kind of the nonpolar oil to a volatile acyclic silicone oil, a viscosity ratio of 7.9 or more can be achieved even if the mass ratio of the linear higher fatty acid to the monohydric higher alcohol is less than 0.50.
Claims (9)
1. An oil-in-water type emulsified cosmetic composition comprising:
a dispersion medium comprising water; and
oil droplets dispersed in the dispersion medium,
the oil droplets contain an oil component, a linear higher fatty acid having 16 or more carbon atoms, a monohydric higher alcohol, and a nonionic surfactant,
the oil component contains at least one kind selected from a polar oil having an IOB of 0.10 or more and an ultraviolet absorber having an IOB of 0.10 or more,
viscosity V measured at 0.6rpm using a B-type viscometer at 30 ℃ in an atmosphere 0.6rpm With a viscosity V measured at 12rpm 12rpm Viscosity ratio V of 0.6rpm /V 12rpm Is 7.9 or more.
2. The cosmetic according to claim 1, wherein the mass ratio of the linear higher fatty acid to the monohydric higher alcohol is 0.50 or more.
3. The cosmetic according to claim 1 or 2, wherein the linear higher fatty acid, the higher alcohol, and the nonionic surfactant form an interfacial film of the oil droplets under an atmosphere of 25 ℃.
4. The cosmetic preparation according to any one of claims 1 to 3, wherein the linear higher fatty acid is at least one selected from stearic acid and behenic acid, and the higher alcohol is at least one selected from cetyl alcohol, isostearyl alcohol, stearyl alcohol and behenyl alcohol.
5. The cosmetic according to any one of claims 1 to 4, wherein the oil component contains at least 50% by mass of at least one selected from a polar oil having an IOB of 0.10 or more and an ultraviolet absorber having an IOB of 0.10 or more.
6. The cosmetic according to any one of claims 1 to 5, further comprising a dihydric higher alcohol.
7. The cosmetic according to any one of claims 1 to 6, wherein the oil component further comprises a volatile acyclic silicone oil.
8. The cosmetic according to any one of claims 1 to 7, further comprising at least one selected from a whitening agent and an anti-inflammatory agent.
9. The cosmetic according to any one of claims 1 to 8, wherein the content of the thickener is 1% by mass or less.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019227333 | 2019-12-17 | ||
JP2019-227333 | 2019-12-17 | ||
PCT/JP2020/046107 WO2021125051A1 (en) | 2019-12-17 | 2020-12-10 | Oil-in-water emulsion cosmetic composition |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114867449A true CN114867449A (en) | 2022-08-05 |
Family
ID=76476565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202080087123.7A Pending CN114867449A (en) | 2019-12-17 | 2020-12-10 | Oil-in-water type emulsified cosmetic |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPWO2021125051A1 (en) |
CN (1) | CN114867449A (en) |
WO (1) | WO2021125051A1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011236199A (en) * | 2010-04-13 | 2011-11-24 | Shiseido Co Ltd | Oil-in-water emulsion composition |
CN102596151A (en) * | 2009-09-04 | 2012-07-18 | 株式会社资生堂 | Method for producing O/W emulsion composition |
CN102858309A (en) * | 2010-04-13 | 2013-01-02 | 株式会社资生堂 | Oil-in-water emulsion composition |
JP2017200894A (en) * | 2016-05-06 | 2017-11-09 | 株式会社ちふれ化粧品 | Oil-in-water emulsion composition having thixotropy |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3696443B2 (en) * | 1999-07-30 | 2005-09-21 | 花王株式会社 | Oil-in-water emulsified cosmetic |
JP5148787B2 (en) * | 2001-02-08 | 2013-02-20 | サンスター株式会社 | Oral composition |
JP3766070B2 (en) * | 2003-04-10 | 2006-04-12 | ピアス株式会社 | Water resistant O / W cosmetics with UV protection effect |
EP1935934B1 (en) * | 2006-12-21 | 2012-07-18 | Arkema France | Rheology additive in the form of a pre-activated paste |
JP4729126B2 (en) * | 2009-09-04 | 2011-07-20 | 株式会社 資生堂 | Method for producing high viscosity O / W cream |
JP2018203624A (en) * | 2017-05-30 | 2018-12-27 | 株式会社コーセー | Emulsion cosmetic |
-
2020
- 2020-12-10 WO PCT/JP2020/046107 patent/WO2021125051A1/en active Application Filing
- 2020-12-10 JP JP2021565536A patent/JPWO2021125051A1/ja active Pending
- 2020-12-10 CN CN202080087123.7A patent/CN114867449A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102596151A (en) * | 2009-09-04 | 2012-07-18 | 株式会社资生堂 | Method for producing O/W emulsion composition |
JP2011236199A (en) * | 2010-04-13 | 2011-11-24 | Shiseido Co Ltd | Oil-in-water emulsion composition |
CN102858309A (en) * | 2010-04-13 | 2013-01-02 | 株式会社资生堂 | Oil-in-water emulsion composition |
JP2017200894A (en) * | 2016-05-06 | 2017-11-09 | 株式会社ちふれ化粧品 | Oil-in-water emulsion composition having thixotropy |
Also Published As
Publication number | Publication date |
---|---|
JPWO2021125051A1 (en) | 2021-06-24 |
WO2021125051A1 (en) | 2021-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2749265B1 (en) | Water-in-oil emulsion sunscreen cosmetic | |
JP4863411B2 (en) | Oil-in-water emulsified sunscreen cosmetics | |
TW201827036A (en) | Oil-in-water type emulsion cosmetic | |
TWI593427B (en) | Oil water emulsion cosmetic | |
JP6847827B2 (en) | Composition for nanoemulsion emulsification, bicontinuous microemulsion, cosmetics and method for producing them | |
JP5913411B2 (en) | Oil-in-water emulsified cosmetic | |
JP5227991B2 (en) | O / W emulsion composition | |
EP2692333B1 (en) | Water-in-oil emulsified cosmetic | |
JP2009242326A (en) | Skin-lightening liquid cosmetic | |
JP6133618B2 (en) | Water-in-oil emulsion composition | |
JP6418626B2 (en) | Water-in-oil emulsified composition and water-in-oil emulsified cosmetic using the composition | |
JP5189836B2 (en) | Oil-containing cosmetic composition | |
JP5117208B2 (en) | Highly polar oil-containing oil-in-water ultrafine emulsion external preparation and method for producing the oil-in-water ultrafine emulsion external preparation | |
JP5243078B2 (en) | Highly polar oil-containing oil-in-water ultrafine emulsion external preparation and method for producing the oil-in-water ultrafine emulsion external preparation | |
CN114867449A (en) | Oil-in-water type emulsified cosmetic | |
JP2018123067A (en) | Oil-in-water cosmetics | |
CN114617784A (en) | Oil-in-water type emulsified cosmetic | |
JP2021123590A (en) | Water-in-oil emulsion cosmetic | |
JP2011111446A (en) | Sunscreen cosmetic | |
WO2015066877A1 (en) | Composition comprising surfactants and hydrophilic active ingredients | |
JP4275872B2 (en) | Mixing topical skin composition for use | |
JP7138269B2 (en) | Liquid crystal emulsion composition and method for producing the same | |
JP5607916B2 (en) | Sunscreen cosmetics | |
WO2022264841A1 (en) | Oil-in-water emulsion cosmetic | |
JP2011111447A (en) | Sunscreen cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |